Docket Management
Docket: 02N-0209 - Request for Comment on First Amendment Issues
Comment Number: EC -227

Accepted - Volume 4

Comment Record
Commentor Ms. Rita Kampf Date/Time 2002-07-27 12:13:13
Organization Ms. Rita Kampf
Category Dietary Supplement Industry

Comments for FDA General
1. Are there arguments for regulating speech about drugs more comprehensively than, for example, about dietary supplements? What must an administrative record contain to sustain such a position? In particular, could FDA sustain a position that certain promotional speech about drugs is inherently misleading, unless it complies with FDA requirements? Does anything turn on whether the speech is made to learned intermediaries or to consumers? What is the evidentiary basis of such a distinction? Of course, drugs should be regulated. Supplements should be left to the individual. If someone it taking a supplement, they investigate it before buying it. With a drug, knowing that there can be serious ramifications with one drug, let along another two of three which often interact with each other. Drugs kill, foood does't.
2. Is FDA's current position regarding direct-to-consumer and other advertisements consistent with empirical research on the effects of those advertisements, as well as with relevant legal authority? What are the positive and negative effects, if any, of industry's promotion of prescription drugs, biologics, and/or devices? Does the current regulatory approach and its implementation by industry lead to over-prescription of drugs? Do they increase physician visits or patient compliance with medication regimes? Do they cause patient visits that lead to treatment for under-diagnosed diseases? Does FDA's current approach and its implementation by industry lead to adequate treatment for under-diagnosed diseases? Do they lead to adequate patient understanding of the potential risks associated with use of drugs? Does FDA's current approach and its implementation by industry create any impediments to the ability of doctors to give optimal medical advice or prescribe optimal treatment? I concur with the DSHEA Law. Although I find the drug advertisements amazing, I think that they have served as a deterrent rather than a promotion for most people. After they get done disclosing about the drug, most people will know that the drug is dangerous and cannot be taken with other drugs which is something that many people didn't know before. I hope that the drug companies have shot themselves in the foot with the advertisements. Just leave it alone.
3. May FDA distinguish claims concerning conventional foods from those relating to dietary supplements, taking into account limits on claims that can be made about foods in the Nutrition Labeling and Education Act, 21 U.S.C. 301, 321, 337, 343, 371? What must an administrative record contain to sustain or deny claims on food labels? How can information best be presented in a succinct but non-misleading fashion? To what extent do assertions in claims need qualifications or disclaimers added to the label to avoid any misconceptions that consumers may draw? Is there a basis to believe that consumers approach claims about conventional foods and dietary supplements differently? The consumer should be thought of as intellegent enough to make their own choices. I look at food and dietary supplements that are food as the same. We don't need the government telling us what to take.
4. Should disclaimers be required to be in the same (or smaller or larger) size of type and given equal prominence with claims? Is there any relevant authority or social science research on this issue? NO
5. How can warnings be made most effective in preventing harm while minimizing the chances of consumer confusion or inattention? Is there any evidence as to which types of warnings consumers follow or disregard? Warnings belong to drug companies
6. What arguments or social science evidence, if any, can be used to support distinguishing between claims made in advertisements and those made on labels? Does the First Amendment and the relevant social science evidence afford the Government greater latitude over labels? If the companies have research validating what the product actually do, then they should be allowed to educate the consumer.
7. Would permitting speech by manufacturer, distributor, and marketer about off-label uses undermine the act's requirement that new uses must be approved by the FDA? If so, how? If not, why not? What is the extent of FDA's ability to regulate speech concerning off-label uses? of Course. If you can't explain the applications of the product, how can the consumer be educated? Leave the DSHEA Law in place exactly as it is.
8. Do FDA's speech-related regulations advance the public health concerns they are designed to address? Are there other alternative approaches that FDA could pursue to accomplish those objectives with fewer restrictions on speech? No....How in the world can you think that food supplements need to be regulated when the drugs are killing people every day. Food and/or supplements don't kill people.
9. Are there any regulations, guidance, policies, and practices FDA should change, in light of governing First Amendment authority? No. FDA needs to stay out of this. Go put more regulations on your friends, the drug companies.

EC -227